FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019011307> ?p ?o ?g. }

• W2019011307 endingPage "771" @default.
• W2019011307 startingPage "766" @default.
• W2019011307 abstract "Objectives. To evaluate the relationship between the severity of necrotizing enterocolitis (NEC) and circulating concentrations of proinflammatory cytokines interleukin (IL)-1β and IL-8 and counterinflammatory cytokines IL-1 receptor antagonist (IL-1ra) and IL-10. These cytokines have been associated with bowel injury or inflammation and may be released more slowly or later than previously examined cytokines. Also, to determine if any one of these cytokines will predict the eventual severity of NEC when measured at symptom onset. Method. Serial blood samples at onset, 8, 24, 48, and 72 hours were obtained from newborn infants with predefined signs and symptoms of NEC. Normal levels were defined from weight-, gestation-, and age-matched controls. Concentrations of the four cytokines were determined by enzyme-linked immunosorbent assay and compared throughout the time period by stage of NEC, using sepsis as a co-factor. Mean concentrations of each cytokine at onset were compared with the controls. Threshold values were obtained with the best combination of high sensitivity and high specificity for defining stage 1 NEC or for diagnosing stage 3 NEC at onset. Results. There were 12 cases of stage 1, 18 cases of stage 2, and 6 cases of stage 3 NEC included in the study, as well as 20 control infants. Concentrations of IL-8 and IL-10 were significantly higher in infants with stage 3 NEC from onset through 24 hours compared with infants with less severe NEC. At onset, concentrations of all four cytokines were significantly higher in stage 3 NEC. To identify, at onset, the infants with a final diagnosis of stage 3 NEC, an IL-1ra concentration of &gt;130 000 pg/mL had a sensitivity of 100% and a specificity of 92%. At 8 hours, an IL-10 concentration of &gt;250 pg/mL had a sensitivity of 100% and a specificity of 90% in identifying stage 3 NEC in infants with symptoms suggestive of NEC at onset. Conclusions. The severity of NEC and its systemic signs and symptoms are not due to a deficiency of counterregulatory cytokines. In fact, mean concentrations of IL-1ra in NEC are higher than what has been reported in other populations. The cytokines IL-8, IL-1ra, and IL-10 are released later or more slowly after a stimulus and may be more useful in identifying, within hours of symptom onset, which infant will develop significant NEC." @default.
• W2019011307 created "2016-06-24" @default.
• W2019011307 creator A5018496293 @default.
• W2019011307 creator A5056390323 @default.
• W2019011307 creator A5074171015 @default.
• W2019011307 date "1999-04-01" @default.
• W2019011307 modified "2023-10-17" @default.
• W2019011307 title "Circulating Pro- and Counterinflammatory Cytokine Levels and Severity in Necrotizing Enterocolitis" @default.
• W2019011307 cites W1497298414 @default.
• W2019011307 cites W1879207397 @default.
• W2019011307 cites W1984189215 @default.
• W2019011307 cites W1996073048 @default.
• W2019011307 cites W2000119033 @default.
• W2019011307 cites W2001998616 @default.
• W2019011307 cites W2002768840 @default.
• W2019011307 cites W2003671526 @default.
• W2019011307 cites W2006164662 @default.
• W2019011307 cites W2011543410 @default.
• W2019011307 cites W2015250987 @default.
• W2019011307 cites W2016551181 @default.
• W2019011307 cites W2025738510 @default.
• W2019011307 cites W2036500213 @default.
• W2019011307 cites W2052233731 @default.
• W2019011307 cites W2063844486 @default.
• W2019011307 cites W2075189548 @default.
• W2019011307 cites W2077704628 @default.
• W2019011307 cites W2106058347 @default.
• W2019011307 cites W2116519404 @default.
• W2019011307 cites W2118110579 @default.
• W2019011307 cites W2168900210 @default.
• W2019011307 cites W2301034803 @default.
• W2019011307 cites W2401079225 @default.
• W2019011307 cites W4302442523 @default.
• W2019011307 doi "https://doi.org/10.1542/peds.103.4.766" @default.
• W2019011307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10103300" @default.
• W2019011307 hasPublicationYear "1999" @default.
• W2019011307 type Work @default.
• W2019011307 sameAs 2019011307 @default.
• W2019011307 citedByCount "220" @default.
• W2019011307 countsByYear W20190113072012 @default.
• W2019011307 countsByYear W20190113072013 @default.
• W2019011307 countsByYear W20190113072014 @default.
• W2019011307 countsByYear W20190113072015 @default.
• W2019011307 countsByYear W20190113072016 @default.
• W2019011307 countsByYear W20190113072017 @default.
• W2019011307 countsByYear W20190113072018 @default.
• W2019011307 countsByYear W20190113072019 @default.
• W2019011307 countsByYear W20190113072020 @default.
• W2019011307 countsByYear W20190113072021 @default.
• W2019011307 countsByYear W20190113072022 @default.
• W2019011307 countsByYear W20190113072023 @default.
• W2019011307 crossrefType "journal-article" @default.
• W2019011307 hasAuthorship W2019011307A5018496293 @default.
• W2019011307 hasAuthorship W2019011307A5056390323 @default.
• W2019011307 hasAuthorship W2019011307A5074171015 @default.
• W2019011307 hasConcept C11988809 @default.
• W2019011307 hasConcept C126322002 @default.
• W2019011307 hasConcept C146357865 @default.
• W2019011307 hasConcept C151730666 @default.
• W2019011307 hasConcept C164027704 @default.
• W2019011307 hasConcept C203014093 @default.
• W2019011307 hasConcept C2776258884 @default.
• W2019011307 hasConcept C2776914184 @default.
• W2019011307 hasConcept C2778384902 @default.
• W2019011307 hasConcept C2778690821 @default.
• W2019011307 hasConcept C2779234561 @default.
• W2019011307 hasConcept C2779303187 @default.
• W2019011307 hasConcept C46973012 @default.
• W2019011307 hasConcept C54355233 @default.
• W2019011307 hasConcept C71924100 @default.
• W2019011307 hasConcept C86803240 @default.
• W2019011307 hasConcept C90924648 @default.
• W2019011307 hasConceptScore W2019011307C11988809 @default.
• W2019011307 hasConceptScore W2019011307C126322002 @default.
• W2019011307 hasConceptScore W2019011307C146357865 @default.
• W2019011307 hasConceptScore W2019011307C151730666 @default.
• W2019011307 hasConceptScore W2019011307C164027704 @default.
• W2019011307 hasConceptScore W2019011307C203014093 @default.
• W2019011307 hasConceptScore W2019011307C2776258884 @default.
• W2019011307 hasConceptScore W2019011307C2776914184 @default.
• W2019011307 hasConceptScore W2019011307C2778384902 @default.
• W2019011307 hasConceptScore W2019011307C2778690821 @default.
• W2019011307 hasConceptScore W2019011307C2779234561 @default.
• W2019011307 hasConceptScore W2019011307C2779303187 @default.
• W2019011307 hasConceptScore W2019011307C46973012 @default.
• W2019011307 hasConceptScore W2019011307C54355233 @default.
• W2019011307 hasConceptScore W2019011307C71924100 @default.
• W2019011307 hasConceptScore W2019011307C86803240 @default.
• W2019011307 hasConceptScore W2019011307C90924648 @default.
• W2019011307 hasIssue "4" @default.
• W2019011307 hasLocation W20190113071 @default.
• W2019011307 hasLocation W20190113072 @default.
• W2019011307 hasOpenAccess W2019011307 @default.
• W2019011307 hasPrimaryLocation W20190113071 @default.
• W2019011307 hasRelatedWork W1601041689 @default.
• W2019011307 hasRelatedWork W1963808434 @default.
• W2019011307 hasRelatedWork W2019011307 @default.
• W2019011307 hasRelatedWork W2070650056 @default.

• next